What AstraZeneca PLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 1 |
| Total trades | 3 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 6 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sharma Mani | SVP, Group Controller | Aug 06 | Grant / award · A | +2 | $163.34 | +$327 | 19,267 |
| Sharma Mani | See Remarks | Jul 06 | Grant / award · A | +2 | $190.43 | +$381 | 19,265 |
| Sharma Mani | See Remarks | Jun 08 | Grant / award · A | +1 | $179.75 | +$180 | 19,263 |
| Sharma Mani | See Remarks | May 20 | Open-market sale · S | −11,893 | $185.78 | −$2.21M | 19,262 |
| Sharma Mani | See Remarks | May 06 | Grant / award · A | +1 | $186.28 | +$186 | 31,155 |
| Sharma Mani | See Remarks | Apr 07 | Grant / award · A | +1 | $196.03 | +$196 | 31,154 |
Loading...